ARCHIVES

Rituximab and Fludarabine Combination Produces Long-Term Remissions in CLL

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Includes 8-page Business & Regulatory Report.

April 11, 2003

Roswell Park Wins High Priority Score, Full Budget Recommendation For Core Grant.

January 11, 2008

Cancer Act Impact; Mortality Decline; DeVita Tells ACCC

October 9, 1992

ASCO And ESMO Publish Training Recommendations

November 26, 2004

NCI Oks Expanded Breast Cancer Low Fat Prevention Trial, Plans To End Stage 2 Adjuvant Low Fat Study

January 31, 1986

“We Will Move Forward With Bold Expectations,” NCI Director Says

October 2, 1998